<p>Ig anti-PA levels from blood draws between day -1 and 65 were analyzed by repeated measures ANOVA.</p><p>The Ig anti-PA response of non-vaccinated groups (None and Vehicle, not shown above) were significantly lower (p < 0.0001) than every other group except each other.</p><p><sup>↓</sup>Indicates the Ig anti-PA response of the vaccine group listed on the left is significantly less than the corresponding vaccine group listed on the top of the table.</p><p><sup>↑</sup>Indicates the Ig anti-PA response of the vaccine group listed on the left is significantly greater than the corresponding vaccine group listed on the top of the table.</p><p>NS, no statistical significance between the two groups.</p><p>p Values Associated with Comparison of I...
Mucosal IgG antibodies to all individual PCS types (PCS1 through PCS12) were collectively treated as...
<p>Percentage of vaccinees with neutralization titers of ≥20 (left panels) and GMT (right panels) ag...
(A) Plasma from animals vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV (day 28)...
<p>(A) An ELISA was performed to measure the mean reciprocal titer of circulating anti-MARV GP IgG f...
<p>Data is given in mean ± SD. *P<0.05 is the comparison done against Normal group using Student's t...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
<p>Shown p-values represent the significance of the correlation between 7dpv-plasmablast frequency a...
<p>The presence of P1-specific IgGs and IgAs was measured by Imperacer® and data are presented as th...
Anti-S (blue) and anti-RBD (red) Abs were measured on Day0, 21, 42, 90, 180 and 270 (n = 56). Cut-of...
Anti-Sh28GST IgG antibody levels in placebo- and vaccine-treated groups from V1 to V11.</p
<p>(A) Anti-LPS IgG, (B) anti-H IgG, and (C) anti-Vi IgG. Clear circles, non-typhoid diagnosed parti...
<p>Samples were collected two weeks after the completion of the immunization schedule and were assay...
<p>For each vaccination group, significant differences between either of the re-stimulation treatmen...
*<p>No significant difference in age was observed between the groups of samples showing high and low...
IgG (A) and IgA (B) RC values express the average change per day and were estimated for two subseque...
Mucosal IgG antibodies to all individual PCS types (PCS1 through PCS12) were collectively treated as...
<p>Percentage of vaccinees with neutralization titers of ≥20 (left panels) and GMT (right panels) ag...
(A) Plasma from animals vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV (day 28)...
<p>(A) An ELISA was performed to measure the mean reciprocal titer of circulating anti-MARV GP IgG f...
<p>Data is given in mean ± SD. *P<0.05 is the comparison done against Normal group using Student's t...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
<p>Shown p-values represent the significance of the correlation between 7dpv-plasmablast frequency a...
<p>The presence of P1-specific IgGs and IgAs was measured by Imperacer® and data are presented as th...
Anti-S (blue) and anti-RBD (red) Abs were measured on Day0, 21, 42, 90, 180 and 270 (n = 56). Cut-of...
Anti-Sh28GST IgG antibody levels in placebo- and vaccine-treated groups from V1 to V11.</p
<p>(A) Anti-LPS IgG, (B) anti-H IgG, and (C) anti-Vi IgG. Clear circles, non-typhoid diagnosed parti...
<p>Samples were collected two weeks after the completion of the immunization schedule and were assay...
<p>For each vaccination group, significant differences between either of the re-stimulation treatmen...
*<p>No significant difference in age was observed between the groups of samples showing high and low...
IgG (A) and IgA (B) RC values express the average change per day and were estimated for two subseque...
Mucosal IgG antibodies to all individual PCS types (PCS1 through PCS12) were collectively treated as...
<p>Percentage of vaccinees with neutralization titers of ≥20 (left panels) and GMT (right panels) ag...
(A) Plasma from animals vaccinated with monovalent A/Singapore/GP1908/2015 (H1N1) WPV or SV (day 28)...